Literature DB >> 8403565

Predictive value of small crescents in IgA nephropathy: analysis of four patients showing a deteriorated renal function during a long follow-up period.

O Hotta1, Y Taguma, K Kurosawa, K Sudo, K Suzuki, I Horigome.   

Abstract

Four patients with IgA nephropathy developed a chronic renal failure during a long follow-up period ranging from three to 8.5 years (mean 6.4 years). All patients showed a normal renal function, normal blood pressure and mild proteinuria at the time of the first renal biopsy. The first biopsies showed focal mesangial proliferation with small cellular crescents in a small percentage of the observed glomeruli. No case showed sclerotic changes in the interstitium and vessels. In contrast, at the second biopsies, all of them exhibited a deteriorated renal function, hypertension and massive proteinuria. The second biopsies revealed marked sclerotic changes in the glomeruli, interstitium, and vessels with significant focal segmental glomerular sclerosis and adhesions. Since no established factors predisposing the patients to chronic renal insufficiency had been observed at the time of the first biopsy, it was suggested that small crescents, even if focal, should be regarded as indicating an unfavorable prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8403565

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

1.  Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.

Authors:  Norio Ieiri; Osamu Hotta; Toshinobu Sato; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2011-09-13       Impact factor: 2.801

2.  (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion.

Authors:  Kaori Narumi; Emiko Sato; Takuo Hirose; Tae Yamamoto; Takashi Nakamichi; Mariko Miyazaki; Hiroshi Sato; Sadayoshi Ito
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.